Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe date has been updated from January 31, 2025, to March 6, 2025.SummaryDifference0.7%
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check49 days agoChange DetectedThe website has been updated to version 2.14.2 on January 31, 2025, following the removal of version 2.14.1 on November 1, 2024.SummaryDifference1%
- Check64 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.